Ledger.Open graph →
SEC Form D · filed January 4, 2021

Cytrellis Biosystems, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WOBURN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Keith L. Crandell · WOBURN, MADirectorKaren Cronholm · WOBURN, MAExec · DirectorFrederick L. Beddingfield Iii, Md · WOBURN, MADirectorMichael L. Peterson · Cedar Falls, IADirectorJohn Mcdonough · Cambridge, MADirectorDiane Marcou · Waltham, MAExecFred L. Aslan, Md · WOBURN, MADirectorMichael L. Peterson · Moline, ILDirectorFrederick L. Beddingfield Iii, Md · WOBURN, MADirectorKeith L. Crandell · Cambridge, MADirectorJohn Mcdonough · Lexington, MADirectorDiane Marcou · WOBURN, MAExecKaren Cronholm · WOBURN, MAExec · DirectorFred L. Aslan, Md · WOBURN, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗